Drug Review Reorganization Boosts Advisory Role Of Medical Imaging Division
Executive Summary
FDA's reorganization of its drug review divisions will allow the Office of New Drugs' medical imaging staff to assume a broader role in consulting on trials that use medical images as an endpoint